drugset / Trial / NCT00273429

Cosopt Versus Xalatan

NCT00273429

RandomizedCrossoverDouble-blindTreatment

Summary

To compare the 24-hour efficacy and safety, measured every three hours, of the dorzolamide/timolol fixed combination given twice daily versus latanoprost and placebo each given once daily.

Timeline

Start
2005-04
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule 0.005 %
Subject Timolol Other / unclassified 0.5 %
Subject dorzolamide/timolol Unknown